AtaiBeckley (ATAI) Share-based Compensation (2020 - 2026)

AtaiBeckley (ATAI) reported Share-based Compensation of $21.4 million for Q3 2025, up 4180.0% on a YoY basis from $500000.0 in Q3 2024, and up 921.97% sequentially from $2.1 million in Q2 2025.

AtaiBeckley (ATAI) Share-based Compensation (2020 - 2026) Analysis & Trends

AtaiBeckley's Share-based Compensation history runs 2 years deep, the most recent figure standing at $50.8 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 1414.16% year-over-year to $50.8 million in Q1 2026; TTM through Mar 2026 was $50.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $14.2 million, down 44.24% from the prior year.
  • Share-based Compensation improved to $21.4 million in Q3 2025, from $2.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $50.8 million in Q1 2026 and bottomed at $3.4 million in Q1 2025.
  • A 5-year average of $6.5 million and a median of $6.0 million in 2024 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation plunged 99.38% in 2022 and jumped 5750.47% in 2024, its largest moves.
  • Tracing ATAI's Share-based Compensation over 5 years: stood at $13.4 million in 2021, then decreased by 9.39% to $12.1 million in 2022, then sank by 39.83% to $7.3 million in 2023, then climbed by 15.02% to $8.4 million in 2024, then soared by 154.7% to $21.4 million in 2025.
  • Business Quant data shows ATAI's Share-based Compensation at $21.4 million in Q3 2025, $2.1 million in Q2 2025, and $8.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 AtaiBeckley 2.56 Bn 2.56 Bn - 21.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.80 Mn
Mar 31, 2026 50.80 Mn
Sep 30, 2025 21.40 Mn
Sep 30, 2025 21.40 Mn
Jun 30, 2025 2.09 Mn
Jun 30, 2025 2.09 Mn
Mar 31, 2025 3.36 Mn
Mar 31, 2025 3.36 Mn
Dec 31, 2024 8.40 Mn
Dec 31, 2024 8.40 Mn
Sep 30, 2024 500,000.00
Sep 30, 2024 500,000.00
Jun 30, 2024 6.26 Mn
Jun 30, 2024 6.26 Mn
Mar 31, 2024 5.76 Mn
Mar 31, 2024 5.76 Mn
Dec 31, 2023 7.31 Mn
Dec 31, 2023 7.31 Mn
Sep 30, 2023 4.86 Mn
Sep 30, 2023 4.86 Mn